.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,592,902

« Back to Dashboard

Details for Patent: 6,592,902

Title: Controlled release eplerenone compositions
Abstract:The invention relates to oral pharmaceutical compositions useful as aldosterone receptor blockers comprising the active agent micronized eplerenone in an amount of about 10 mg to about 1000 mg and one or more carrier materials.
Inventor(s): Thosar; Shilpa S. (Des Plaines, IL), Gokhale; Rajeev D. (Waukegan, IL), Tolbert; Dwain S. (Wadsworth, IL)
Assignee:
Filing Date:Jan 31, 2002
Application Number:10/066,360
Claims:1. A pharmaceutical composition comprising (a) particulate eplerenone having a D.sub.90 particle size of about 25 to about 400 microns, in an amount of about 10 mg to about 1000 mg, and (b) one or more pharmaceutically acceptable carrier materials; said composition being a controlled release oral dosage form wherein about 50% of said eplerenone is dissolved in vitro in at least about 1.5 hours in a 1% sodium dodecyl sulfate solution at 37.degree. C.

2. The pharmaceutical composition of claim 1 that comprises: about 24% to about 35% by weight of said eplerenone; about 25% to about 45% by weight of lactose; about 10% to about 25% by weight of microcrystalline cellulose; and about 5% to about 50% by weight of hydroxypropylmethylcellulose.

3. The pharmaceutical composition of claim 1 wherein about 50% of said eplerenone is released during a two hour period after ingestion of the composition, as measured by in vitro dissolution in a 1% sodium dodecyl sulfate solution at 37.degree. C.

4. The pharmaceutical composition of claim 3 that comprises about 2% to about 20% by weight of high molecular weight hydroxypropylmethylcellulose.

5. The pharmaceutical composition of claim 1 wherein about 50% of said eplerenone is released during a four hour period after ingestion of the composition, as measured by in vitro dissolution in a 1% sodium dodecyl sulfate solution at 37.degree. C.

6. The pharmaceutical composition of claim 5 that comprises about 5% to about 45% by weight of high molecular weight hydroxypropylmethylcellulose.

7. The pharmaceutical composition of claim 1 wherein about 50% of said eplerenone is released during a six hour period after ingestion of the composition, as measured by in vitro dissolution in a 1% sodium dodecyl sulfate solution at 37.degree. C.

8. The pharmaceutical composition of claim 7 that comprises about 10% to about 45% by weight of high molecular weight hydroxypropylmethylcellulose.

9. The pharmaceutical composition of claim 1 wherein about 50% of said eplerenone is dissolved in vitro in at least about 3.5 hours in a 1% sodium dodecyl sulfate solution at 37.degree. C.

10. The pharmaceutical composition of claim 1 wherein about 50% of said eplerenone is dissolved in vitro in at least about 5.5 hours in a 1% sodium dodecyl sulfate solution at 37.degree. C.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc